Name: Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (scDiabody-CH3)
SKU: SCDBC-044
Rating: 5 (1 reviews)

Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (scDiabody-CH3) is a fusion protein of two scDiabodies connected together by a CH3 region. In single-chain Diabodies, an additional connecting linker is introduced between chains of the anti-CD19/anti-CD64 diabody. The scDiabody with two specificities is fused to each of the CH3 chains to extend half-life. This BsAb can retarget neutrophils to tumor cells. It is designed for the research of B cell lymphoma; Leukemia therapy.

Datasheet INQUIRY

Specifications

Targets

CD19 & CD64

Type

scDiabody-CH3

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

B cell lymphoma; Leukemia

Host Animal 1

Mouse

Host Animal 2

Mouse

Targets

Target 1

CD19

Gene ID

930

UniProt ID

P15391

Alternative Names

CD19; CD19 molecule; Cluster of differentiation 19; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4

Target 2

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (scDiabody-CH3) (SCDBC-044). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (scDiabody-CH3) (CAT#: SCDBC-044)

Specifications

Targets

Customer Reviews and Q&As